Philly Xarelto Warning Claims Not Preempted, Judge Rules

Law360, Philadelphia (November 2, 2017, 8:55 PM EDT) -- A Pennsylvania judge recently ruled that failure-to-warn claims in consolidated litigation over alleged injuries from Janssen Pharmaceuticals Inc. and Bayer AG’s blood thinner Xarelto were not preempted by federal law.

The Johnson & Johnson unit and Bayer had argued that failure-to-warn claims in a Philadelphia County mass tort program over the blood thinner were preempted by federal law. But in a one-page order Tuesday, Court of Common Pleas Judge Arnold L. New disagreed and denied partial summary judgment to the drug companies. The ruling affects all...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.